Literature DB >> 7677873

Effect of alfacalcidol on renal bone disease in mild to moderate renal failure. Questions remain over alfacalcidol's efficacy in preventing secondary hyperparathyroidism.

A Fournier, N E Esper, P Moriniere, R Oprisiu, A Marie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7677873      PMCID： PMC2550137          DOI： 10.1136/bmj.311.6997.124b

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Soft tissue calcification in pediatric patients with end-stage renal disease.

Authors:  D S Milliner; A R Zinsmeister; E Lieberman; B Landing
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  Preventing renal bone disease in moderate renal failure with CaCO3 and 25(OH) vitamin D3.

Authors:  A Fournier; A Idrissi; J L Sebert; J Gueris; M Garabedian; H Renaud; P F Westeel
Journal:  Kidney Int Suppl       Date:  1988-03       Impact factor: 10.545

3.  Ketodiet, physiological calcium intake and native vitamin D improve renal osteodystrophy.

Authors:  M H Lafage; C Combe; A Fournier; M Aparicio
Journal:  Kidney Int       Date:  1992-11       Impact factor: 10.612

4.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.